2022 Pharmacotherapy Preparatory Review and Recertification Course -- Critical Care, Chronic Care in Cardiology, Acute Care in Cardiology, and Anticoagulation

Sunday, April 24, 2022 from 8:00 AM to 12:45 PM CDT
at Academic and Research Building: First Floor, Room 111
Available for 5.25 hours of CPE credit
Activity Number: 0217-0000-22-013-L01-P

Pharmacotherapy Preparatory Review and Recertification Course is ideal for pharmacy professionals preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination, for Board Certified Pharmacotherapy Specialists (BCPSs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of pharmacotherapy topics.

Developed and presented by board-certified pharmacotherapy specialists, the course provides a comprehensive review of the knowledge domains covered in the pharmacotherapy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Interpret hemodynamic parameters and acid-base status in critically ill patients.
2. Differentiate between presentation of and treatment strategies for hypovolemic, obstructive, cardiogenic, and distributive shock.
3. Employ the appropriate use of fluids, vasopressors, antibiotics, and corticosteroids in patients with sepsis or septic shock.
4. Recommend strategies to optimize care for targeted temperature management after cardiac arrest and for acute intracranial hemorrhage.
5. Manage therapeutic options to minimize delirium and provide optimal analgesia, sedation, neuromuscular blockade, and nutritional support in critically ill patients.
6. Select therapeutic options to prevent stress ulcers, venous thromboembolism, hyperglycemia, and ventilator-associated pneumonia in critically ill patients.
7. Recommend patient-specific pharmacologic therapy for the management of chronic heart failure, with an emphasis on mortality-reducing agents and their target doses.
8. Develop an evidence-based pharmacologic regimen and monitoring plan for patients with atrial fibrillation.
9. Develop an optimal pharmacologic management plan for a patient with hypertension according to practice guidelines and clinical trial evidence.
10. Design an appropriate dyslipidemia regimen based on a patient􀂶s atherosclerotic cardiovascular disease (ASCVD) risk.
11. Determine the appropriate pharmacologic therapy for patients with stable coronary heart disease.
12. Distinguish between the treatments for acute coronary syndrome: ST-segment elevation myocardial infarction and non􀂱ST-segment elevation acute coronary syndrome.
13. Formulate evidence-based treatment strategies for patients with acute decompensated heart failure.
14. Devise a treatment plan for patients presenting with ventricular or life-threatening arrhythmias.
15. Differentiate between goals and treatment for hypertensive emergencies and hypertension without progressive organ damage.
16. Recommend a patient-specific pharmacotherapy plan to reduce the risk of stroke in patients with atrial fibrillation.
17. Develop a feasible pharmacologic management plan to reduce thrombotic events in patients receiving aortic or mitral valve replacement.
18. Devise an evidence-based pharmacotherapy plan for preventing and treating venous thromboembolism (VTE).
19. Analyze the need for anticoagulant therapy in patients with atrial fibrillation or VTE.
20. Determine appropriate reversal strategies for patients at risk of bleeding, or actively bleeding, while receiving anticoagulation therapy.
21. Determine appropriate selection and dosing of anticoagulant therapy on the basis of patient-specific factors and drug interactions.

Critical Care 8:00 AM to 9:00 AM Speakers Speaker: Corey J. Witenko, Pharm.D., FCCM, BCCCP, BCPS Medical Science / Clinical Trial Liaison​, ​Theravance Biopharma​ New York, New York View Biography Witenko

Chronic Care in Cardiology 9:00 AM to 10:25 AM Speakers Speaker: Caitlin M. Gibson, Pharm.D., BCCP, BCPS Associate Professor Virginia Commonwealth University School of Pharmacy Richmond, Virginia View Biography Gibson

Acute Care in Cardiology 10:35 AM to 11:50 AM Speakers Speaker: Shannon W. Finks, Pharm.D., FCCP, BCCP, BCPS Professor of Clinical Pharmacy and Translational Science, University of Tennessee College of Pharmacy  President, ZüpMedical Services, LLC, Memphis, Tennessee View Biography Finks

Anticoagulation 11:50 AM to 12:45 PM Speakers Speaker: Paul P. Dobesh, Pharm.D., FCCP, BCCP, BCPS Professor of Pharmacy Practice and Science University of Nebraska Medical Center College of Pharmacy Omaha, Nebraska View Biography Dobesh